The impact of leptin and its receptor polymorphisms on type 1 diabetes in a population of northwest Iran

Background Diabetes comprises a serious disease with significant growth in the number of cases in recent years. Here, we cover the gap in information between leptin (LEP) and type 1 diabetes in the Iranian population. Aim To recognise LEP G2548A and LEP receptor Q223R polymorphisms in Iranian people...

Full description

Bibliographic Details
Main Authors: Parviz Azimnasab-sorkhabi, Maryam Soltani-asl, José Roberto Kfoury, Petra Algenstaedt, Hakan Farzin Mehmetzade, Yashar Hashemi Aghdam
Format: Article
Language:English
Published: Taylor & Francis Group 2022-11-01
Series:Annals of Human Biology
Subjects:
Online Access:http://dx.doi.org/10.1080/03014460.2022.2134453
_version_ 1797685203800424448
author Parviz Azimnasab-sorkhabi
Maryam Soltani-asl
José Roberto Kfoury
Petra Algenstaedt
Hakan Farzin Mehmetzade
Yashar Hashemi Aghdam
author_facet Parviz Azimnasab-sorkhabi
Maryam Soltani-asl
José Roberto Kfoury
Petra Algenstaedt
Hakan Farzin Mehmetzade
Yashar Hashemi Aghdam
author_sort Parviz Azimnasab-sorkhabi
collection DOAJ
description Background Diabetes comprises a serious disease with significant growth in the number of cases in recent years. Here, we cover the gap in information between leptin (LEP) and type 1 diabetes in the Iranian population. Aim To recognise LEP G2548A and LEP receptor Q223R polymorphisms in Iranian people and their association with type 1 diabetes susceptibility. Subjects and methods Characteristics such as fasting blood sugar (FBS) were measured in 80 control non-diabetic individuals and 89 diabetic patients. Moreover, LEP G2548A and LEP receptor Q223R polymorphisms were genotyped using polymerase chain reaction-restriction fragment length polymorphism technique. Results The frequency of the A allele was nearly three times greater in diabetes patients than in the control group. In addition, in the diabetes group, the AA genotype was five times greater than in the control group (p < 0.01). Furthermore, AA and AA + AG genotype models had higher FBS levels than the GG + AG and GG genotype models, respectively (p < 0.01). Conclusion The LEP G2548A polymorphism could be related to type 1 diabetes susceptibility, but not LEPR Q223R polymorphism in the Iranian population. Importantly, further studies are essential to examine the impact of LEP G2548A and LEPR Q223R polymorphisms in the endocrinology area.
first_indexed 2024-03-12T00:40:46Z
format Article
id doaj.art-e8691ec000f948c9b5365c8457918d1f
institution Directory Open Access Journal
issn 0301-4460
1464-5033
language English
last_indexed 2024-03-12T00:40:46Z
publishDate 2022-11-01
publisher Taylor & Francis Group
record_format Article
series Annals of Human Biology
spelling doaj.art-e8691ec000f948c9b5365c8457918d1f2023-09-15T08:45:20ZengTaylor & Francis GroupAnnals of Human Biology0301-44601464-50332022-11-01497-831732210.1080/03014460.2022.21344532134453The impact of leptin and its receptor polymorphisms on type 1 diabetes in a population of northwest IranParviz Azimnasab-sorkhabi0Maryam Soltani-asl1José Roberto Kfoury2Petra Algenstaedt3Hakan Farzin Mehmetzade4Yashar Hashemi Aghdam5Department of Biology, Faculty of Science, Islamic Azad UniversityDepartment of Biology, Faculty of Science, Islamic Azad UniversityDepartment of Surgery, School of Veterinary Medicine and Animal Sciences, University of Sao PauloMedical Clinic and Polyclinic of University of Hamburg, Eppendorf UniversityDepartment of Medical Microbiology, Hacettepe UniversityDepartment of Traumatology, Spine and Orthopedic Surgery, Asklepios Hospital Altona, Faculty of Medicine, University of HamburgBackground Diabetes comprises a serious disease with significant growth in the number of cases in recent years. Here, we cover the gap in information between leptin (LEP) and type 1 diabetes in the Iranian population. Aim To recognise LEP G2548A and LEP receptor Q223R polymorphisms in Iranian people and their association with type 1 diabetes susceptibility. Subjects and methods Characteristics such as fasting blood sugar (FBS) were measured in 80 control non-diabetic individuals and 89 diabetic patients. Moreover, LEP G2548A and LEP receptor Q223R polymorphisms were genotyped using polymerase chain reaction-restriction fragment length polymorphism technique. Results The frequency of the A allele was nearly three times greater in diabetes patients than in the control group. In addition, in the diabetes group, the AA genotype was five times greater than in the control group (p < 0.01). Furthermore, AA and AA + AG genotype models had higher FBS levels than the GG + AG and GG genotype models, respectively (p < 0.01). Conclusion The LEP G2548A polymorphism could be related to type 1 diabetes susceptibility, but not LEPR Q223R polymorphism in the Iranian population. Importantly, further studies are essential to examine the impact of LEP G2548A and LEPR Q223R polymorphisms in the endocrinology area.http://dx.doi.org/10.1080/03014460.2022.2134453leptinleptin receptorpolymorphismtype 1 diabetes
spellingShingle Parviz Azimnasab-sorkhabi
Maryam Soltani-asl
José Roberto Kfoury
Petra Algenstaedt
Hakan Farzin Mehmetzade
Yashar Hashemi Aghdam
The impact of leptin and its receptor polymorphisms on type 1 diabetes in a population of northwest Iran
Annals of Human Biology
leptin
leptin receptor
polymorphism
type 1 diabetes
title The impact of leptin and its receptor polymorphisms on type 1 diabetes in a population of northwest Iran
title_full The impact of leptin and its receptor polymorphisms on type 1 diabetes in a population of northwest Iran
title_fullStr The impact of leptin and its receptor polymorphisms on type 1 diabetes in a population of northwest Iran
title_full_unstemmed The impact of leptin and its receptor polymorphisms on type 1 diabetes in a population of northwest Iran
title_short The impact of leptin and its receptor polymorphisms on type 1 diabetes in a population of northwest Iran
title_sort impact of leptin and its receptor polymorphisms on type 1 diabetes in a population of northwest iran
topic leptin
leptin receptor
polymorphism
type 1 diabetes
url http://dx.doi.org/10.1080/03014460.2022.2134453
work_keys_str_mv AT parvizazimnasabsorkhabi theimpactofleptinanditsreceptorpolymorphismsontype1diabetesinapopulationofnorthwestiran
AT maryamsoltaniasl theimpactofleptinanditsreceptorpolymorphismsontype1diabetesinapopulationofnorthwestiran
AT joserobertokfoury theimpactofleptinanditsreceptorpolymorphismsontype1diabetesinapopulationofnorthwestiran
AT petraalgenstaedt theimpactofleptinanditsreceptorpolymorphismsontype1diabetesinapopulationofnorthwestiran
AT hakanfarzinmehmetzade theimpactofleptinanditsreceptorpolymorphismsontype1diabetesinapopulationofnorthwestiran
AT yasharhashemiaghdam theimpactofleptinanditsreceptorpolymorphismsontype1diabetesinapopulationofnorthwestiran
AT parvizazimnasabsorkhabi impactofleptinanditsreceptorpolymorphismsontype1diabetesinapopulationofnorthwestiran
AT maryamsoltaniasl impactofleptinanditsreceptorpolymorphismsontype1diabetesinapopulationofnorthwestiran
AT joserobertokfoury impactofleptinanditsreceptorpolymorphismsontype1diabetesinapopulationofnorthwestiran
AT petraalgenstaedt impactofleptinanditsreceptorpolymorphismsontype1diabetesinapopulationofnorthwestiran
AT hakanfarzinmehmetzade impactofleptinanditsreceptorpolymorphismsontype1diabetesinapopulationofnorthwestiran
AT yasharhashemiaghdam impactofleptinanditsreceptorpolymorphismsontype1diabetesinapopulationofnorthwestiran